These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10639248)

  • 21. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.
    Reimer KA; Vander Heide RS; Richard VJ
    Am J Cardiol; 1993 Dec; 72(19):13G-21G. PubMed ID: 8279349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury.
    Mocanu MM; Baxter GF; Yellon DM
    Br J Pharmacol; 2000 May; 130(2):197-200. PubMed ID: 10807653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?
    Balakumar P; Rohilla A; Singh M
    Pharmacol Res; 2008 Jun; 57(6):403-12. PubMed ID: 18586514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reperfusion-induced injury: a possible role for oxidant stress and its manipulation.
    Hearse DJ
    Cardiovasc Drugs Ther; 1991 Mar; 5 Suppl 2():225-35. PubMed ID: 1854665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction.
    Zhu JX; Kalbfleisch M; Yang YX; Bihari R; Lobb I; Davison M; Mok A; Cepinskas G; Lawendy AR; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1218-27. PubMed ID: 23046222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unresolved issues in myocardial reperfusion injury.
    Buja LM; Weerasinghe P
    Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
    Lecour S
    J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editor's Choice- Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death.
    van der Weg K; Prinzen FW; Gorgels AP
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):142-152. PubMed ID: 30421619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on.
    Baxter GF
    Basic Res Cardiol; 2002 Jul; 97(4):268-75. PubMed ID: 12111036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stuttering Reperfusion of Ischemic Myocardium Does Not Exacerbate Myocardial Infarction: Evidence Against Lethal Cell Reperfusion Injury in the Rabbit.
    Alker KJ; Bellows SD; Kloner RA
    J Thromb Thrombolysis; 1996; 3(3):185-188. PubMed ID: 10613981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
    Davidson SM; Hausenloy D; Duchen MR; Yellon DM
    Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmet goals in the treatment of Acute Myocardial Infarction: Review.
    Farah A; Barbagelata A
    F1000Res; 2017; 6():. PubMed ID: 29034073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathobiology and Clinical Impact of Reperfusion Injury.
    Birnbaum Y; Leor J; Kloner RA
    J Thromb Thrombolysis; 1995; 2(3):177-186. PubMed ID: 10608022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology and Clinical Impact of Reperfusion Injury.
    Birnbaum Y; Leor J; Kloner RA
    J Thromb Thrombolysis; 1997; 4(2):185-195. PubMed ID: 10639261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in Therapies for Myocardial Ischemia Reperfusion Injury.
    Chi HJ; Chen ML; Yang XC; Lin XM; Sun H; Zhao WS; Qi D; Dong JL; Cai J
    Curr Drug Targets; 2017; 18(15):1712-1721. PubMed ID: 27033199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury.
    Davani EY; Brumme Z; Singhera GK; Côté HC; Harrigan PR; Dorscheid DR
    Crit Care; 2003 Dec; 7(6):R176-83. PubMed ID: 14624693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis and hepatic allograft reperfusion injury.
    Kuo PC; Drachenberg CI; de la Torre A; Bartlett ST; Lim JW; Plotkin JS; Johnson LB
    Clin Transplant; 1998 Jun; 12(3):219-23. PubMed ID: 9642513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
    Zhang Y; Liu X; She ZG; Jiang DS; Wan N; Xia H; Zhu XH; Wei X; Zhang XD; Li H
    Basic Res Cardiol; 2014; 109(5):434. PubMed ID: 25150882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.